Hospitals
London has 303 hospitals (including both NHS hospitals and private hospitals).
London has firmly established itself as Europe’s life sciences powerhouse, serving as a critical anchor of the UK’s "Golden Triangle" alongside Oxford and Cambridge.
The city is globally renowned for its unparalleled academic research excellence, housing three of the world’s top universities for health and clinical science and the iconic Francis Crick Institute. This dense concentration of talent fuels a vibrant biotechnology sector, with London attracting record-breaking venture capital investment for drug discovery and advanced therapies.
Beyond R&D, the capital is a strategic hub for the pharmaceutical industry, hosting the global headquarters or major commercial operations for 19 of the world’s top 20 pharma giants.
The ecosystem thrives on healthcare innovation, uniquely integrated with the National Health Service (NHS) to provide a world-class environment for clinical trials and real-world evidence. Within specialized clusters like the Knowledge Quarter and White City Innovation District, a booming techbio movement is leveraging artificial intelligence to accelerate precision medicine and genomics.
London’s medical device and medtech sectors are equally robust, pioneering digital health solutions and surgical robotics that transform patient outcomes.
With a massive pipeline of new laboratory space and incubators, the city offers a seamless "concept to clinic" pathway for startups and multinationals alike.
Consequently, London remains the premier destination for global partners seeking a connected, data-rich and highly collaborative life sciences ecosystem.
London has 303 hospitals (including both NHS hospitals and private hospitals).
There are 39 universities with full degree-awarding powers within the city proper.
London has received around £290 million to £300 million (around $368 million to $381 million USD) in government funding across its four National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRCs), including £95.3 million for Imperial ($121 million), £90.2 million for UCL/UCLH ($115 million), £64.4 million for Guy’s & St Thomas’/King’s ($82 million) and £41 million for Maudsley ($52 million).
London’s life sciences and health-AI ecosystem drew approximately $1.2 billion in venture capital investment in 2023.
London hosts over 2,400 life sciences companies, ranked among Europe’s top destinations for sector growth.
Big pharma presence in London includes GSK, Vertex Pharmaceuticals, Jazz Pharmaceuticals, ViiV Healthcare, Advanz Pharma and others.
London hosts a diverse and innovative medtech sector, which includes companies such as Roche Diagnostics, Odin Vision, Dotplot, ZIO Health and more.
There are ~2,600 active clinical studies registered in London, UK.
London, UK
Employment in life sciences rose from ~19,400 in 2008 to ~34,800 in 2021 to 2022 (11 % of UK total), marking a 29% increase, the largest growth among UK regions.
Currently, London has around 700,000 ft² of lab space. By the end of 2026, the lab space constructed is projected to nearly double compared with 2021 to 2024 levels to 2 million ft², with potential expansion to 7.2 million ft² by 2032, including 2.7 million ft² of wet lab space.
https://www.grow.london/
Claim Profile to Update Contact Information
Claim Your Profile to Add Related Links
Claim Your Profile to add downloadable documentation
https://pharmaville.com/wp-content/uploads/2026/02/Pharmaville-London-references-1.pdf